Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial
<i>Background and Objectives:</i> Cancer therapy containing anthracyclines is associated with cancer-treatment-related cardiac dysfunction and heart failure (HF). Conventional cardioprotective medications can be frequently complicated by their blood-pressure-lowering effect. Recently, elevated resti...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2023-12-01
|
| Col·lecció: | Medicina |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1648-9144/59/12/2140 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|